TTA in Treatment of Diabetes and Dyslipidemia

NCT00605787 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Dyslipidemia

Interventions

DRUG: Tetradecylthioacetic acid (TTA)

Sponsor

Haukeland University Hospital

Collaborators

[object Object]